“…In recent years, many industries and scientific disciplines have embraced the concept of high throughput experimentation (HTE) to support the ever-increasing need for faster data generation and acceleration of product development cycles. In pharmaceutical industry, HTE has been adopted in diverse areas, such as the discovery of biomarkers and of new chemical entities in drug discovery, [1][2][3] as a ABBREVIATIONS: ADE, acoustic droplet ejection; AEMS, acoustic ejection mass spectrometry; AIMS, ambient ionization mass spectrometry; AMI, acoustic mist ionization; AP, atmospheric pressure; APCI, atmospheric-pressure chemical ionization; APPI, atmospheric-pressure photoionization; BPR, back pressure regulator; CD, circular dichroism; DART, direct analysis in real-time; DESI, desorption electrospray ionization; FPP, fully porous particles; HTA, high throughput analysis; HTE, high throughput experimentation; HTS, high throughput screening; IMS, ion mobility spectrometry; MISER, multiple injections in a single experimental run; OPI, open port interface; OT, open tubular; SAMDI, self-assembled monolayers coupled with desorption/ionization; SFC, supercritical fluid chromatography; SIMS, secondary ion mass spectrometry; SPME, solid-phase microextraction; SPP, superficially porous particles; UHPLC, ultrahigh-performance liquid chromatography/ultrahigh-pressure liquid chromatography; UV, ultraviolet This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. © 2021 The Authors.…”